A Clinical Trial of TQ05105 Tablets in the Treatment of Chronic Graft-versus-host Disease — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(12 sites)
China
Anhui Provincial Hospital, Hefei, Anhui The 940th hospital of joint logistics support force of Chinese people's liberation army, Lanzhou, Gansu Guangzhou First People's Hospital, Guangzhou, Guangdong The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei Xiangyang Central Hospital, Xiangyang, Hubei Tai'an Central Hospital, Taian, Shangdong Ruijin Hospital affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai Municipality The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shannxi Hematology Hospital of the Chinese Academy of Medical Sciences, Tianjin, Tianjin Municipality The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang The Affiliated People's Hospital of Ningbo University, Ningbo, Zhejiang Last updated February 2025